Biocon Pharma gets GMP compliance certificate from UK's health regulator MHRA for Bengaluru facility
The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection

New Delhi: Biotechnology firm Biocon on Monday said its subsidiary Biocon Pharma has received Good Manufacturing Practice (GMP) compliance certificate from UK's health regulator MHRA for its Bengaluru facility."Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom (UK), for its manufacturing facility at Biocon Park in Bengaluru," Biocon said in a regulatory filing.The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of 22 March, 2021, in the wake of travel restrictions amidst COVID-19, the company added.Shares of Biocon were trading 0.08 percent lower at Rs 419.95 apiece on BSE.

Stroke is rising among young adults. Doctor explains why it's happening and what you must do
Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge
Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs
Spices, health and the Indian plate: Why chilli can be good for you—but moderation is still key
Organ donation: 5 myths you need to stop believing, according to a transplant specialist
